AdaptHealth Corp. (NASDAQ:AHCO) Shares Sold by Vanguard Group Inc.

Vanguard Group Inc. lessened its stake in AdaptHealth Corp. (NASDAQ:AHCO) by 0.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,540,674 shares of the company’s stock after selling 14,495 shares during the quarter. Vanguard Group Inc. owned 9.32% of AdaptHealth worth $119,387,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in AHCO. KLP Kapitalforvaltning AS purchased a new position in AdaptHealth in the fourth quarter valued at about $169,000. Sei Investments Co. raised its holdings in AdaptHealth by 8.5% during the fourth quarter. Sei Investments Co. now owns 366,246 shares of the company’s stock worth $3,487,000 after purchasing an additional 28,633 shares during the last quarter. American Century Companies Inc. boosted its position in AdaptHealth by 30.2% during the fourth quarter. American Century Companies Inc. now owns 210,359 shares of the company’s stock worth $2,003,000 after purchasing an additional 48,736 shares in the last quarter. Teacher Retirement System of Texas grew its holdings in AdaptHealth by 134.1% in the fourth quarter. Teacher Retirement System of Texas now owns 45,225 shares of the company’s stock valued at $431,000 after purchasing an additional 25,909 shares during the last quarter. Finally, Intech Investment Management LLC increased its position in shares of AdaptHealth by 100.2% in the fourth quarter. Intech Investment Management LLC now owns 119,417 shares of the company’s stock valued at $1,137,000 after buying an additional 59,767 shares in the last quarter. Institutional investors and hedge funds own 82.67% of the company’s stock.

Wall Street Analyst Weigh In

AHCO has been the topic of several recent research reports. Royal Bank of Canada boosted their price objective on shares of AdaptHealth from $11.00 to $14.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 26th. Robert W. Baird upped their price target on shares of AdaptHealth from $14.00 to $16.00 and gave the company an “outperform” rating in a report on Thursday, February 27th. UBS Group lowered their price target on shares of AdaptHealth from $12.00 to $11.00 and set a “buy” rating on the stock in a research report on Thursday, February 13th. Truist Financial lifted their price objective on AdaptHealth from $12.00 to $14.00 and gave the stock a “buy” rating in a research report on Wednesday, February 26th. Finally, Canaccord Genuity Group increased their target price on AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a report on Wednesday, February 26th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $13.80.

AdaptHealth Price Performance

AdaptHealth stock opened at $9.00 on Wednesday. The stock has a market capitalization of $1.21 billion, a P/E ratio of -5.45, a P/E/G ratio of 1.08 and a beta of 1.44. AdaptHealth Corp. has a 12-month low of $8.35 and a 12-month high of $11.90. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00. The firm’s 50-day moving average is $9.95 and its two-hundred day moving average is $10.10.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.